Mr Anthony Clare > Stephenson Harwood > London, England > Lawyer Profile

Stephenson Harwood
1 FINSBURY CIRCUS
LONDON
EC2M 7SH
England

Work Department

Corporate

Position

Anthony is a corporate partner specialising in M&A and corporate finance. He covers a range of sectors, with particular market recognition in life sciences and biotechnology.

Anthony advises on a wide range of corporate matters including M&A (public and private), joint ventures and equity capital markets. He has acted on over 20 IPOs in the London market, with a particular bias towards issuer-side mandates. He is well known in the biotech industry and has served for over nine years on the board, and as Vice Chairman, of The Babraham Institute, Cambridge – one of Europe’s leading bioscience research institutes. Anthony is also a board trustee of the Institute of Cancer Research, one of the world’s most influential cancer research institutions.

Anthony is named as a ‘star’ in the corporate section of the 2015 edition of LMG Life Sciences and listed in the Top 50 European M&A lawyers 2014 by Global M&A Network (EMEA).

Lawyer Rankings

London > Industry focus > Life sciences and healthcare

Stephenson Harwood‘s team is skilled in addressing a range of issues for clients, including strategic collaborations, funding rounds, and life sciences M&A. The unit is led by the ‘commercially astute’ Alexandra Pygall, whose practice spans partnering agreements and IP disputes linked to partnering deals. Dan Holland has deep knowledge of clinical and commercial supply agreements. Anthony Clare is equipped to handle public and private life sciences M&A. Early-stage research, collaboration and licensing agreements are key practice strengths of Naomi Leach.

London > Corporate and commercial > M&A: Lower Mid-Market Deals, £100m-£750m

The corporate finance team at Stephenson Harwood takes a multidisciplinary approach, working alongside other practices including tax, banking and finance, and technology to advise on transactions. The group has a strong industry coverage, with particular expertise in the financial services, decarbonisation, transport and trade, technology, and healthcare sectors. It has recently seen an uptick in cross-border transactions for technology businesses. Sam Gray concentrates on cross-border M&A transactions, predominantly acting for insurance brokers and clients from the financial services sector. Duncan Stiles stands out for his extensive experience assisting US companies on European-focused acquisitions, while Ben Mercer is adept in private M&A, joint ventures, and restructuring. Life sciences and biotechnology expert Anthony Clare and corporate department head Tom Nicholls focus on public and private M&A and joint ventures- including in relation to venture capital. On the healthcare front, Karima Hudson – who rejoined the team from Taylor Wessing LLP in June 2023 – specialises in advising both operators and funders in the healthcare space. Other notable names include Jonathan Bridcut and Michelle Gomes.